AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pulsed Radiofrequency Versus 5% Dextrose Injection in Chronic Plantar Fasciitis

RecruitingNAAges 18 Years - 70 YearsAllAnkara City Hospital Bilkent
💬

In plain words

What the trial is, and whether it could suit you

This prospective, two-center, randomized controlled clinical trial aims to compare the effectiveness of ultrasound-guided pulsed radiofrequency and 5% dextrose injection in patients with chronic plantar fasciitis. Eligible participants will be randomized into two parallel groups. One group will receive ultrasound-guided pulsed radiofrequency treatment, and the other group will receive ultrasound-guided 5% dextrose injection using the peppering technique. All participants will receive a home-based plantar fascia stretching exercise program. Outcomes will be assessed at baseline, 3 weeks, 6 weeks, and 12 weeks after treatment. The primary outcome will be pain intensity measured by the Numeric Rating Scale. Secondary outcomes will include foot function, activity-related pain, ankle-hindfoot function, and health-related quality of life.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of chronic plantar fasciitis based on medical history and physical examination * Heel pain resistant to conservative treatment for at least 12 weeks * Age between 18 and 70 years * Willingness to participate in the study and provide written informed consent Exclusion Criteria: * Congenital or acquired disease that may impair or prevent foot function, such as rheumatoid arthritis, hemiplegia, congenital foot deformity, traumatic foot or leg amputation, or fracture sequelae * Local infection or skin disease at the treatment site * Bleeding disorder or use of anticoagulant medication within the last week * Disease causing mental dysfunction, such as uncontrolled Parkinson disease or Alzheimer disease * Previous surgery for plantar fasciitis * Refusal to participate in the study or inability to provide informed consent * Failure to attend follow-up visits after treatment * Request to withdraw from the study * Pregnancy or suspected pregnancy * Presence of a cardiac pacemaker * History of epilepsy * Active or previous malignancy * Rheumatologic disease
💊

What it tests

  • Ultrasound-Guided Pulsed Radiofrequency Treatment
  • Ultrasound-Guided 5% Dextrose Injection
📍

Where

1 site
Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy